These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8732580)

  • 1. Pharmacokinetics of pyropheophorbide-a-hexyl ether in the dog.
    Payne JT; McCaw DL; Casteel SW; Frazier D; Rogers K; Tompson RV
    Lasers Surg Med; 1996; 18(4):406-9. PubMed ID: 8732580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
    Furukawa K; Yamamoto H; Crean DH; Kato H; Mang TS
    Lasers Surg Med; 1996; 18(2):157-66. PubMed ID: 8833284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy for sarcoma pulmonary metastases: a preclinical toxicity study.
    Anderson TM; Dougherty TJ; Tan D; Sumlin A; Schlossin JM; Kanter PM
    Anticancer Res; 2003; 23(5A):3713-8. PubMed ID: 14666668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of canine hemangiopericytomas with photodynamic therapy.
    McCaw DL; Payne JT; Pope ER; West MK; Tompson RV; Tate D
    Lasers Surg Med; 2001; 29(1):23-6. PubMed ID: 11500858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
    Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
    Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.
    Lobel J; MacDonald IJ; Ciesielski MJ; Barone T; Potter WR; Pollina J; Plunkett RJ; Fenstermaker RA; Dougherty TJ
    Lasers Surg Med; 2001; 29(5):397-405. PubMed ID: 11891727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer.
    Magne ML; Rodriguez CO; Autry SA; Edwards BF; Theon AP; Madewell BR
    Lasers Surg Med; 1997; 20(2):202-9. PubMed ID: 9047175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
    Potter WR; Henderson BW; Bellnier DA; Pandey RK; Vaughan LA; Weishaupt KR; Dougherty TJ
    Photochem Photobiol; 1999 Nov; 70(5):781-8. PubMed ID: 10568170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.
    Wang S; Fan W; Kim G; Hah HJ; Lee YE; Kopelman R; Ethirajan M; Gupta A; Goswami LN; Pera P; Morgan J; Pandey RK
    Lasers Surg Med; 2011 Sep; 43(7):686-95. PubMed ID: 22057496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
    Bellnier DA; Henderson BW; Pandey RK; Potter WR; Dougherty TJ
    J Photochem Photobiol B; 1993 Sep; 20(1):55-61. PubMed ID: 8229470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives.
    MacDonald IJ; Morgan J; Bellnier DA; Paszkiewicz GM; Whitaker JE; Litchfield DJ; Dougherty TJ
    Photochem Photobiol; 1999 Nov; 70(5):789-97. PubMed ID: 10568171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of a physiologically based pharmacokinetic model for HPPH in rats and extrapolate to humans.
    Chen L; Zhang X; Cao Q; Wu Y; Zhang T; Tong H; Wang X; Yang J
    Eur J Pharm Sci; 2019 Mar; 129():68-78. PubMed ID: 30597205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical compartmental pharmacokinetic modeling of 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) as a photosensitizer in rat plasma by validated HPLC method.
    Krishna KV; Saha RN; Puri A; Viard M; Shapiro BA; Dubey SK
    Photochem Photobiol Sci; 2019 May; 18(5):1056-1063. PubMed ID: 30608096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.
    Rigual N; Shafirstein G; Cooper MT; Baumann H; Bellnier DA; Sunar U; Tracy EC; Rohrbach DJ; Wilding G; Tan W; Sullivan M; Merzianu M; Henderson BW
    Clin Cancer Res; 2013 Dec; 19(23):6605-13. PubMed ID: 24088736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic modeling and simulation of HPPH in Chinese patients with esophageal carcinoma.
    Chen L; Ye X; Hu K; Zhai Y; Li W; Wang X; Yang J
    Xenobiotica; 2020 Feb; 50(2):170-177. PubMed ID: 30901299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
    Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoscopic fluorescence tomography of a photosensitizer (HPPH) 3D biodistribution in skin cancer.
    Ozturk MS; Rohrbach D; Sunar U; Intes X
    Acad Radiol; 2014 Feb; 21(2):271-80. PubMed ID: 24439340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I Study of Light Dose for Photodynamic Therapy Using 2-[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a for the Treatment of Non-Small Cell Carcinoma In Situ or Non-Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study.
    Dhillon SS; Demmy TL; Yendamuri S; Loewen G; Nwogu C; Cooper M; Henderson BW
    J Thorac Oncol; 2016 Feb; 11(2):234-41. PubMed ID: 26718878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.